drugset / Trial / NCT00886808
Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The goal of the study is to evaluate the safety and tolerability of 4 different doses of iCo-007 Intravitreal Injection in patients with diffuse diabetic macular edema.
Timeline
- Start
- 2008-02
- Primary completion
- 2010-05
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | iCo-007 | Unknown | 110 ug | Intravitreal |
| Subject | iCo-007 | Unknown | 350 ug | Intravitreal |
| Subject | iCo-007 | Unknown | 700 ug | Intravitreal |
| Subject | iCo-007 | Unknown | 1000 ug | Intravitreal |